Hematological Toxicity in Mice after High Activity Injections of (177)Lu-PSMA-617

Prostate cancer (PC) is one of the most common malignancies affecting men, with poor prognosis after progression to metastatic castration-resistant prostate cancer (mCRPC). Radioligand therapy (RLT) targeting the overexpressed PSMA on PC cells, with, e.g., (177)Lu-PSMA-617, has been effective in red...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristiansson, Amanda, Vilhelmsson Timmermand, Oskar, Altai, Mohamed, Strand, Joanna, Strand, Sven-Erik, Åkerström, Bo, Örbom, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032768/
https://www.ncbi.nlm.nih.gov/pubmed/35456565
http://dx.doi.org/10.3390/pharmaceutics14040731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032768/
https://www.ncbi.nlm.nih.gov/pubmed/35456565
http://dx.doi.org/10.3390/pharmaceutics14040731

Ejemplares similares